GGrantIndex
Sort

48,018 grants matching immunotherapy

Uncovering the metabolic underpinnings of T cell exhaustion

$1,280,768
Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI

JOHNS HOPKINS ADULT AIDS CLINICAL TRIALS UNIT

$1,280,720
Johns Hopkins University · U01 · FY2002 · AI

Improving the efficacy of anti-nicotine immunotherapy

$1,280,461
Alexey G Mukhin · Duke University · RC2 · FY2010 · DA

First-in-Human (Phase 1) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of IBC-Ab002 in Persons with Early Alzheimer's Disease (AD)

$1,280,437
Eti Yoles · Immunobrain Checkpoint Inc. · R01 · FY2023 · AG

Phase I therapeutic testing of viral-vectored vaccines that shift CD8+ T cell immunodominance to conserved regions of HIV-1

$1,279,617
Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U01 · FY2020 · AI

LJI Epitope Validation Center: Characterization of epitope-specific T cells responding to food, fungal and inner city allergens

$1,279,239
Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2021 · AI

Role of the microbiota in regulating the mononuclear phagocyte system

$1,278,195
Silvana Goldszmid · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Allergen T cell epitopes and phenotypes in peanut allergy and immunotherapy

$1,278,096
William W. Kwok · Benaroya Research Inst At Virginia Mason · U19 · FY2019 · AI

Clinical and Mechanistic Investigations of Salivary Gland Dysfunction

$1,277,652
Blake Warner · National Institute Of Dental & Craniofacial Research · ZIA · FY2020 · DE

Bay Area Team Against Resistance

$1,277,605
Trever G Bivona · University Of California, San Francisco · U54 · FY2019 · CA

Role of the microbiota in regulating the mononuclear phagocyte system

$1,277,572
Romina Goldszmid · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

High Content Pathology

$1,277,435
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2016 · CA

Validation of Serum Neurofilament Light Chain as a Prognostic and Monitoring Biomarker in Multiple Sclerosis

$1,277,337
Peter A Calabresi · Johns Hopkins University · U01 · FY2021 · NS

Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas

$1,277,211
Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2019 · CA

Molecular Mechanisms of Asthma

$1,277,048
Julian Solway · University Of Chicago · P01 · FY2007 · AI

The Boston Lung Cancer Survival Cohort

$1,275,710
David C Christiani · Harvard School Of Public Health · U01 · FY2021 · CA

BIOLOGY AND TRANSPLANTATION OF THE HUMAN STEM CELL

$1,275,301
University Of Minnesota Twin Cities · P01 · FY2000 · CA

Photodynamic Priming of Cancer and Image-guidance for Optimal Immune Response

$1,274,917
Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2022 · CA

Investigating Correlates and Therapeutics of Fatigue in Cancer Patients

$1,274,401
Leorey Saligan · National Institute Of Nursing Research · ZIA · FY2021 · NR

Clonal expansion: a marker of disease activity in stage 1 T1D

$1,273,578
S Alice Long · Benaroya Research Inst At Virginia Mason · R01 · FY2024 · DK

DEFINING IL-4-ACTIVATED MONOCYTES AS VIABLE CELLULAR IMMUNOTHERAPY IN ACUTE LUNG INJURY

$1,273,178
The Johns Hopkins University · · FY2016 · Department of the Army

DLK1 as a novel target for Down syndrome myeloid leukemia

$1,273,073
Anilkumar Gopalakrishnapillai · Nemours Children'S Hospital, Delaware · R01 · FY2025 · CA

Immunological Analysis of Brain Cancer

$1,272,345
Masaki Terabe · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Novel Molecular Therapies of Prostate Cancer

$1,272,322
Dario C. Altieri · Wistar Institute · P01 · FY2016 · CA

Vectored HIV Immunotherapy via in vivo B cell editing

$1,272,001
David T Curiel · Washington University · R01 · FY2025 · AI